A Open Study of Metronomic Oral Vinorelbine in Combination With Aromatase Inhibitors for the Treatment of Postmenopausal Women With Hormone Receptor Positive,HER2-negative, Advanced Breast Cancer Who Received no Prior Therapy for Advanced Disease
Clinical trial NCT02730091 · TERMINATED
Trial details
- NCT number
- NCT02730091
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-24
- Primary completion
- 2020-03-23
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.